#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	232	CRP	633	633	99.53	CRP.l6.c30.ctg.1	1007	12.1	0	.	p	.	0	K29T	NONSYN	85	87	AAG	265	267	ACG	11;11;10	A;C;G	11;11;10	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	110	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.1	112	11.1	0	.	n	.	0	G906T	SNP	906	906	G	11	11	T	6	T	6	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	110	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.1	112	11.1	0	.	n	.	0	G908A	SNP	908	908	G	13	13	A	7	A	7	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	110	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.1	112	11.1	0	.	n	.	0	A918T	SNP	918	918	A	23	23	T	9	T	9	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	110	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.1	112	11.1	0	.	n	.	0	A943G	SNP	943	943	A	48	48	G	20	G	20	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	Chlamydophila_psittaci_16S.3003485.AB001778.1.0_1507.3258	0	0	528	110	Chlamydophila_psittaci_16S	1507	101	95.05	Chlamydophila_psittaci_16S.l15.c4.ctg.1	112	11.1	0	.	n	.	0	G991T	SNP	991	991	G	96	96	T	10	T	10	.	Chlamydophila psittaci 16S rRNA mutation conferring resistance to spectinomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	147	662	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1397	23.2	1	SNP	p	R234F	1	.	.	700	702	TTC	886	888	TTC	29;29;29	T;T;C	28;29;29	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	147	662	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1397	23.2	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1186	1188	CGT	20;21;22	C;G;T	20;21;22	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	147	662	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1397	23.2	0	HET	.	.	.	T999C	.	999	999	T	1185	1185	T	19	T,C	12,7	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	147	662	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1397	23.2	0	HET	.	.	.	T180C	.	180	180	T	366	366	T	26	T,C	10,11	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	147	662	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1397	23.2	0	HET	.	.	.	C261T	.	261	261	C	447	447	C	19	C,T	14,5	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	300	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1527	10.2	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1351	1353	AAA	8;8;8	A;A;A	8;8;8	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	352	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	1520	11.9	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1140	1142	GAA	11;11;11	G;A;A	11;11;11	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	72	H_NS	414	414	99.03	H_NS.l6.c4.ctg.2	558	5.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	270	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1401	10.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	151	153	CGT	4;4;3	C;G;T	4;3;3	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	270	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1401	10.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	235	237	ATC	7;7;7	A;T;C	7;7;7	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	270	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1401	10.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	994	996	GGC	14;14;14	G;G;C	14;14;14	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	452	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	12.6	0	.	p	.	0	R8S	NONSYN	22	24	AGA	154	156	AGC	5;6;6	A;G;C	5;6;6	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	452	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	12.6	0	.	p	.	0	I142L	NONSYN	424	426	ATA	556	558	CTA	16;16;16	C;T;A	16;16;16	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	452	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	12.6	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1075	1077	CAA	9;8;9	C;A;A	9;8;9	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	452	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	12.6	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1174	1176	GGT	7;7;7	G;G;T	7;7;7	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	452	PmrC	1644	1644	99.15	PmrC.l6.c4.ctg.1	1919	12.6	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1744	1746	GTT	12;12;12	G;T;T	12;12;12	.	PmrC;PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	180	PmrE	1167	713	96.49	PmrE.l15.c4.ctg.1	901	7.5	0	.	p	.	0	A125E	NONSYN	373	375	GCA	561	563	GAA	5;5;5	G;A;A	5;5;5	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	180	PmrE	1167	713	96.49	PmrE.l15.c4.ctg.1	901	7.5	0	.	p	.	0	M185T	NONSYN	553	555	ATG	741	743	ACC	4;4;4	A;C;C	4;4;4	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	180	PmrE	1167	713	96.49	PmrE.l15.c4.ctg.1	901	7.5	0	.	p	.	0	S225T	NONSYN	673	675	TCC	861	863	ACT	2;2;2	A;C;T	2;2;2	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	180	PmrE	1167	113	96.46	PmrE.l15.c4.ctg.2	113	5.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	513	180	PmrE	1167	323	97.83	PmrE.l15.c4.ctg.3	323	6.0	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	223	225	ATC	7;7;7	A;T;C	7;7;7	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	228	PmrF	969	969	99.38	PmrF.l15.c4.ctg.2	1144	10.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrF
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	142	aad-	789	789	100.0	aad-.l15.c4.ctg.1	908	7.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	676	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3489	10.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	449	451	ATC	15;15;15	A;T;C	15;15;15	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	676	acrD	3114	3114	99.07	acrD.l6.c30.ctg.1	3489	10.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2162	2164	AAG	5;5;5	A;A;G	5;5;5	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	258	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1338	9.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	169	171	GTC	3;3;4	G;T;C	3;3;4	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	258	acrE	1158	1158	98.79	acrE.l15.c30.ctg.1	1338	9.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	910	912	TGC	13;13;14	T;G;C	13;13;14	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	656	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2777	12.5	0	.	p	.	0	S46trunc	TRUNC	136	136	T	152	152	T	6	T	6	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	656	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2777	12.5	0	.	p	.	0	G148D	NONSYN	442	444	GGC	458	460	GAC	9;9;9	G;A;C	9;9;9	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	656	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2777	12.5	0	.	p	.	0	F240L	NONSYN	718	720	TTT	734	736	TTA	7;7;8	T;T;A	7;7;8	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	656	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2777	12.5	0	.	p	.	0	D301N	NONSYN	901	903	GAT	917	919	AAT	11;10;11	A;A;T	11;10;11	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	656	acrF	3105	2598	98.5	acrF.l6.c4.ctg.1	2777	12.5	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1704	1704	T	17	T	17	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	214	acrR_2	648	648	99.54	acrR_2.l15.c30.ctg.1	1001	11.4	1	SNP	p	R45C	0	.	.	133	135	CGC	289	291	CGC	14;14;14	C;G;C	14;14;14	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	198	acrS	663	663	98.64	acrS.l15.c4.ctg.1	748	12.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	175	177	TTC	8;8;8	T;T;C	8;8;8	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	198	acrS	663	663	98.64	acrS.l15.c4.ctg.1	748	12.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	439	441	GGG	14;14;15	G;G;G	14;14;15	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	258	adiY	762	762	99.61	adiY.l15.c30.ctg.1	1140	12.1	0	.	p	.	0	V136L	NONSYN	406	408	GTT	610	612	CTT	10;9;9	C;T;T	10;9;9	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	513	538	alaS	2631	791	99.24	alaS.l6.c4.ctg.1	980	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	513	538	alaS	2631	1841	98.7	alaS.l6.c4.ctg.2	1896	9.5	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	1062	1064	GCA	8;8;8	G;C;A	8;7;8	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	513	538	alaS	2631	1841	98.7	alaS.l6.c4.ctg.2	1896	9.5	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	1323	1325	ACC	18;18;18	A;C;C	18;18;18	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	513	538	alaS	2631	1841	98.7	alaS.l6.c4.ctg.2	1896	9.5	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	1632	1634	GCC	10;10;10	G;C;C	10;10;10	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	1179	99.07	arnA_1.l15.c4.ctg.2	1179	8.6	0	.	p	.	0	I150V	NONSYN	448	450	ATT	23	25	GTT	3;3;4	G;T;T	3;3;4	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	1179	99.07	arnA_1.l15.c4.ctg.2	1179	8.6	0	.	p	.	0	R200H	NONSYN	598	600	CGC	173	175	CAC	5;5;5	C;A;C	5;5;5	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	1179	99.07	arnA_1.l15.c4.ctg.2	1179	8.6	0	.	p	.	0	T295M	NONSYN	883	885	ACG	458	460	ATG	11;11;10	A;T;G	11;11;10	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	318	98.11	arnA_1.l15.c4.ctg.4	398	3.7	0	.	p	.	0	S607C	NONSYN	1819	1821	AGC	154	156	TGC	2;2;2	T,A;G;C	0,2;2;2	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	318	98.11	arnA_1.l15.c4.ctg.4	398	3.7	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	214	216	CGC	3;3;3	C;G;C	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	135	96.3	arnA_1.l15.c4.ctg.6	135	4.4	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	6	8	TGC	2;3;3	T;G;C	2;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	512	254	arnA_1	1983	130	96.92	arnA_1.l15.c4.ctg.7	132	4.1	0	.	p	.	0	G37A	NONSYN	109	111	GGT	9	11	GCT	3;3;3	G;C;T	3;3;3	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	200	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1013	9.9	0	.	p	.	0	S221T	NONSYN	661	663	AGC	724	726	ACC	5;5;5	A;C;C	5;5;5	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	200	bacA	822	822	98.54	bacA.l15.c30.ctg.1	1013	9.9	0	.	p	.	0	P225S	NONSYN	673	675	CCG	736	738	TCG	4;4;4	T;C;G	4;4;4	.	bacA;bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	19	120	baeR	723	689	97.68	baeR.l6.c4.ctg.1	887	7.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.;baeR
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	224	baeS	1404	1262	98.89	baeS.l6.c4.ctg.1	1444	7.7	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1307	1309	AAA	2;2;2	A;A;A	2;2;2	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	224	baeS	1404	1262	98.89	baeS.l6.c4.ctg.1	1444	7.7	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1319	1321	GAG	4;4;4	G;A;G	4;4;4	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	224	baeS	1404	1262	98.89	baeS.l6.c4.ctg.1	1444	7.7	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1325	1327	CAC	5;5;7	C;A;C	5;5;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	224	baeS	1404	1262	98.89	baeS.l6.c4.ctg.1	1444	7.7	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1379	1381	GAG	7;7;5	G;A;G	7;7;5	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	513	224	baeS	1404	120	99.17	baeS.l6.c4.ctg.2	120	4.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	372	cpxA	1374	1374	98.91	cpxA.l15.c4.ctg.1	1579	12.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	236	cpxR	699	699	99.43	cpxR.l15.c30.ctg.1	965	12.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	196	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1331	7.8	0	.	p	.	0	A146T	NONSYN	436	438	GCT	606	608	ACT	8;8;8	A;C;T	8;8;8	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	90	dfrA1_1	474	474	100.0	dfrA1_1.l6.c30.ctg.1	660	6.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	286	emrA	1173	1173	98.29	emrA.l15.c30.ctg.1	1393	10.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	864	866	GTC	19;19;19	G;T;C	19;19;19	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	402	emrB	1539	1539	99.87	emrB.l15.c4.ctg.1	1810	11.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	789	791	AAA	6;6;6	A;A;A	6;6;6	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	513	328	emrD	1191	1058	98.39	emrD.l6.c4.ctg.1	1259	12.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	826	828	AGC	7;7;8	A;G;C	7;7;8	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	513	328	emrD	1191	90	100.0	emrD.l6.c4.ctg.2	132	6.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	230	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1384	8.8	0	.	p	.	0	K176R	NONSYN	526	528	AAG	694	696	AGG	11;11;12	A;G;G	11;11;12	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	230	emrK	1056	1056	98.2	emrK.l15.c4.ctg.1	1384	8.8	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1084	1086	GAC	5;6;6	G;A;C	5;6;6	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	184	emrR	531	531	100.0	emrR.l15.c30.ctg.1	917	10.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	380	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	1922	10.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	154	evgA	615	615	99.19	evgA.l15.c30.ctg.1	848	9.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	292	294	CTG	11;10;10	C;T;G	11;10;10	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	193	195	AAA	10;10;10	A;A;A	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	928	930	CAT	11;10;11	C;A;T	11;10;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	982	984	CAT	12;12;11	C;A;T	12;12;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1000	1002	AGA	12;12;12	A;G;A	12;12;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1015	1017	AAT	11;11;11	A;A;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1162	1164	TCC	6;7;7	T;C;C	6;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1327	1329	ATT	6;6;6	A;T;T	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1348	1350	GAT	7;6;6	G;A;T	7;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1462	1464	GTT	11;11;11	G;T;T	11;11;11	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	2490	97.87	evgS.l15.c30.ctg.1	2743	11.0	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1747	1749	CAC	10;10;10	C;A;C	10;10;10	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	T38I	NONSYN	112	114	ACA	179	181	ATA	9;9;8	A;T;A	9;9;8	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	L42V	NONSYN	124	126	CTA	191	193	GTA	4;5;6	G;T;A	4;5;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	A93T	NONSYN	277	279	GCG	344	346	ACG	4;5;5	A;C;G	4;5;5	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	A114E	NONSYN	340	342	GCA	407	409	GAA	10;11;12	G;A;A	10;11;12	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	T127A	NONSYN	379	381	ACT	446	448	GCT	16;16;16	G;C;T	16;16;16	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	N133D	NONSYN	397	399	AAT	464	466	GAT	15;14;14	G;A;T	15;14;14	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	P162S	NONSYN	484	486	CCA	551	553	TCA	7;7;7	T;C;A	7;7;7	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	680	682	CAG	9;9;9	C;A;G	9;8;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	I251V	NONSYN	751	753	ATT	818	820	GTT	9;9;9	G;T;T	9;9;9	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	762	evgS	3594	942	97.13	evgS.l15.c30.ctg.2	1009	9.3	0	.	p	.	0	N303D	NONSYN	907	909	AAT	974	976	GAT	3;3;2	G;A;T	3;3;2	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	250	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1174	11.3	1	SNP	p	P64R	0	.	.	190	192	CCA	322	324	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	250	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1174	11.3	1	SNP	p	P64H	0	.	.	190	192	CCA	322	324	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	250	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1174	11.3	1	SNP	p	P64L	0	.	.	190	192	CCA	322	324	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	250	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1174	11.3	1	SNP	p	P64A	0	.	.	190	192	CCA	322	324	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	250	folP_1	849	849	99.29	folP_1.l6.c4.ctg.1	1174	11.3	1	SNP	p	P64S	0	.	.	190	192	CCA	322	324	CCA	12;12;12	C;C;A	12;12;12	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	166	gadE	528	528	100.0	gadE.l15.c30.ctg.1	924	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	16	44	gadW	729	122	95.9	gadW.l15.c4.ctg.1	122	4.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c4.ctg.1	927	11.1	0	.	p	.	0	F53L	NONSYN	157	159	TTC	172	174	TTA	11;10;10	T;T;A	11;10;10	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c4.ctg.1	927	11.1	0	.	p	.	0	V79I	NONSYN	235	237	GTT	250	252	ATT	11;11;13	A;T;T	11;11;13	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c4.ctg.1	927	11.1	0	.	p	.	0	R246G	NONSYN	736	738	AGA	751	753	GGA	6;6;6	G;G;A	6;6;6	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	208	gadX	825	825	97.94	gadX.l6.c4.ctg.1	927	11.1	0	.	p	.	0	S248P	NONSYN	742	744	TCG	757	759	CCG	6;5;5	C;C;G	6;5;5	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2226	2228	GAA	9;9;8	G;A;A	9;9;8	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	S83I	0	.	.	247	249	TCG	441	443	TCG	16;16;16	T;C;G	16;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	S83L	0	.	.	247	249	TCG	441	443	TCG	16;16;16	T;C;G	16;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	S83W	0	.	.	247	249	TCG	441	443	TCG	16;16;16	T;C;G	16;16;16	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	D87V	0	.	.	259	261	GAC	453	455	GAC	14;14;14	G;A;C	13;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	D87Y	0	.	.	259	261	GAC	453	455	GAC	14;14;14	G;A;C	13;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	D87N	0	.	.	259	261	GAC	453	455	GAC	14;14;14	G;A;C	13;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	D87H	0	.	.	259	261	GAC	453	455	GAC	14;14;14	G;A;C	13;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	568	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3010	10.1	1	SNP	p	D87G	0	.	.	259	261	GAC	453	455	GAC	14;14;14	G;A;C	13;14;14	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136E	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136C	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136S	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136G	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136H	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136L	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	19	642	gyrB_1	2415	2404	99.04	gyrB_1.l6.c4.ctg.1	2638	12.6	1	SNP	p	R136I	0	.	.	406	408	CGC	640	642	CGC	9;9;9	C;G;C	9;9;9	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	118	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	845	7.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	301	303	CCG	6;6;6	C;C;G	6;6;6	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	118	kdpE	678	678	98.23	kdpE.l6.c4.ctg.1	845	7.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	454	456	GCC	10;10;10	G;C;C	10;10;10	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	276	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1057	12.7	0	.	p	.	0	P9S	NONSYN	25	27	CCA	69	71	TCA	7;7;7	T;C;A	7;7;7	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	98	marA	384	384	99.74	marA.l6.c4.ctg.1	695	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	V45E	0	.	.	133	135	GTG	146	148	GTG	14;14;14	G;T;G	14;14;14	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	I49S	0	.	.	145	147	ATC	158	160	ATC	10;10;9	A;T;C	10;10;9	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	A70T	0	.	.	208	210	GCA	221	223	GCA	12;12;11	G;C;A	12;12;11	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	R73S	0	.	.	217	219	CGT	230	232	CGT	10;10;10	C;G;T	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	R73C	0	.	.	217	219	CGT	230	232	CGT	10;10;10	C;G;T	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	R77C	0	.	.	229	231	CGC	242	244	CGC	10;10;9	C;G;C	10;10;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	R77L	0	.	.	229	231	CGC	242	244	CGC	10;10;9	C;G;C	10;10;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	251	98.8	marR.l15.c30.ctg.2	265	9.4	1	SNP	p	L78M	0	.	.	232	234	CTG	245	247	CTG	9;8;8	C;T;G	9;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	187	96.26	marR.l15.c30.ctg.3	187	4.3	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	60	62	AGC	3;2;2	A;G;C	3;2;2	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	187	96.26	marR.l15.c30.ctg.3	187	4.3	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	162	164	CAT	6;6;6	C;A;T	6;6;6	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	187	96.26	marR.l15.c30.ctg.3	187	4.3	1	SNP	p	R94S	0	.	.	280	282	CGC	33	35	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	187	96.26	marR.l15.c30.ctg.3	187	4.3	1	SNP	p	R94H	0	.	.	280	282	CGC	33	35	CGC	4;4;4	C;G;C	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	513	84	marR	435	187	96.26	marR.l15.c30.ctg.3	187	4.3	1	SNP	p	V96E	0	.	.	286	288	GTA	39	41	GTA	4;4;4	G;T;A	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.2	955	8.1	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	60	62	CAG	9;9;9	C;A;G	9;9;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.2	955	8.1	0	.	p	.	0	D128A	NONSYN	382	384	GAC	99	101	GCC	4;4;4	G;C;C	4;4;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.2	955	8.1	0	.	p	.	0	S163A	NONSYN	487	489	TCG	204	206	GCG	5;6;6	G;C;G	5;6;6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.2	955	8.1	0	.	p	.	0	L231V	NONSYN	691	693	CTT	408	410	GTT	7;7;7	G;T;T	6;6;7	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	948	97.78	mdfA.l15.c4.ctg.2	955	8.1	0	.	p	.	0	R285fs	FSHIFT	853	853	C	570	570	C	6	C	6	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	109	92.66	mdfA.l15.c4.ctg.3	109	5.0	0	.	p	.	0	R36I	NONSYN	106	108	AGG	66	68	ATC	5;5;5	A;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	109	92.66	mdfA.l15.c4.ctg.3	109	5.0	0	.	p	.	0	E42A	NONSYN	124	126	GAA	84	86	GCC	1;1;1	G;C;C	1;1;1	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	512	182	mdfA	1233	109	92.66	mdfA.l15.c4.ctg.3	109	5.0	0	.	p	.	0	N43V	NONSYN	127	129	AAT	87	89	GTG	1;1;1	G;T;G	1;1;1	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	162	mdtA	1248	620	98.06	mdtA.l15.c30.ctg.1	620	9.0	0	.	p	.	0	P257T	NONSYN	769	771	CCG	187	189	ACG	6;7;7	A;C;G	6;7;7	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	162	mdtA	1248	135	97.78	mdtA.l15.c30.ctg.2	138	5.5	0	.	p	.	0	I99M	NONSYN	295	297	ATA	37	39	ATG	2;2;3	A;T;G	2;2;3	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	162	mdtA	1248	135	97.78	mdtA.l15.c30.ctg.2	138	5.5	0	.	p	.	0	A130T	NONSYN	388	390	GCC	130	132	ACC	4;4;4	A;C;C	4;4;4	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	162	mdtA	1248	190	95.26	mdtA.l15.c30.ctg.3	198	4.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	48	48	G	5	G	5	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	512	162	mdtA	1248	190	95.26	mdtA.l15.c30.ctg.3	198	4.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	105	107	CAG	1;1;2	C;A;G	1;1;2	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1817	1819	ACC	9;9;10	A;C;C	9;9;10	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2210	2212	CAA	14;14;14	C;A;A	14;14;14	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2378	2380	ATT	5;5;5	A;T;T	5;5;5	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2462	2464	GTT	12;12;12	G;T;T	12;12;12	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2570	2572	GAG	9;9;9	G;A;G	9;9;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2798	2800	ATG	9;9;9	A;T;G	9;9;9	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	694	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3303	11.1	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	2933	2935	GAT	7;9;9	G;A;T	7;9;8	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	536	mdtC	3078	2918	98.77	mdtC.l6.c4.ctg.1	2948	9.5	0	.	p	.	0	I46M	NONSYN	136	138	ATC	164	166	ATG	5;5;5	A;T;G	5;5;5	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	536	mdtC	3078	2918	98.77	mdtC.l6.c4.ctg.1	2948	9.5	0	.	p	.	0	V208I	NONSYN	622	624	GTC	650	652	ATC	9;10;10	A;T;C	9;10;10	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	240	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1671	7.5	0	.	p	.	0	D3E	NONSYN	7	9	GAT	63	65	GAA	3;3;3	G;A;A	3;3;3	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	240	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1671	7.5	0	.	p	.	0	T226A	NONSYN	676	678	ACG	732	734	GCG	8;8;8	G;C;G	8;8;8	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	240	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1671	7.5	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1074	1076	ATC	3;3;3	A;T;C	3;3;3	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	240	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1671	7.5	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1377	1379	TTT	12;12;12	T;T;T	12;12;12	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	420	mdtE	1158	1158	99.31	mdtE.l15.c30.ctg.1	1564	14.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	790	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3587	11.8	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1090	1092	ACC	13;13;13	A;C;C	13;13;13	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	790	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3587	11.8	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2332	2334	GAC	15;16;17	G;A;C	14;15;16	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	268	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1463	8.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	642	644	ATC	6;6;6	A;T;C	6;6;6	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	268	mdtG	1227	157	99.36	mdtG.l15.c4.ctg.3	158	7.8	0	.	p	.	0	E5G	NONSYN	13	15	GAA	8	10	GGA	1;2;2	G;G;A	1;2;2	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	198	mdtH	1209	995	98.09	mdtH.l15.c4.ctg.1	995	8.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	205	207	TGT	12;12;13	T;G;T	12;12;12	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	198	mdtH	1209	995	98.09	mdtH.l15.c4.ctg.1	995	8.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	775	777	TTG	7;7;6	T;T;G	7;7;6	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	198	mdtH	1209	995	98.09	mdtH.l15.c4.ctg.1	995	8.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	985	987	ACG	1;1;1	A;C;G	1;1;1	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	513	198	mdtH	1209	187	98.93	mdtH.l15.c4.ctg.2	187	6.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	346	mdtL	1176	1176	98.38	mdtL.l15.c30.ctg.1	1545	11.9	0	.	p	.	0	A185S	NONSYN	553	555	GCC	750	752	TCC	12;11;11	T;C;C	11;11;11	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	224	mdtN	1032	1032	98.06	mdtN.l15.c4.ctg.1	1424	8.3	0	.	p	.	0	V119I	NONSYN	355	357	GTT	554	556	ATT	2;3;5	A;T;T	2;3;5	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	V11M	NONSYN	31	33	GTG	76	78	ATG	9;9;10	A;T;G	9;8;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	T33I	NONSYN	97	99	ACC	142	144	ATC	8;8;7	A;T;C	8;8;7	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	C116R	NONSYN	346	348	TGC	391	393	CGC	5;5;5	C;G;C	5;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	N238S	NONSYN	712	714	AAC	757	759	AGC	10;10;10	A;G;C	10;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	M305V	NONSYN	913	915	ATG	958	960	GTG	8;8;8	G;T;G	8;6;8	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1021	1023	AAC	5;5;6	A;A;C	5;5;5	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1066	1068	GTC	10;10;10	G;T;C	10;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1096	1098	ATA	8;8;8	A;T;A	8;7;8	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1204	1206	TCT	6;6;6	T;C;T	6;6;6	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1591	1593	GCG	16;16;16	G;C;G	16;16;16	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	434	mdtO	2052	2052	98.15	mdtO.l15.c17.ctg.1	2325	9.8	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1804	1806	ATC	9;10;10	A;T;C	9;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	S129A	NONSYN	385	387	TCA	463	465	GCG	10;10;10	G;C;G	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	A187T	NONSYN	559	561	GCC	637	639	ACC	7;8;9	A;C;C	7;8;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	H211R	NONSYN	631	633	CAC	709	711	CGC	8;9;9	C;G;C	8;9;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	V250A	NONSYN	748	750	GTT	826	828	GCT	7;8;9	G;C;T	7;8;9	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	R278K	NONSYN	832	834	AGA	910	912	AAA	6;6;5	A;A;A	6;6;5	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	928	930	CGA	7;7;9	C;G;A	7;7;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1093	1095	GCC	8;8;8	G;C;C	8;8;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1105	1107	GAT	10;10;10	G;A;T	10;10;10	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	316	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1683	9.8	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1522	1524	GCT	5;5;6	G;C;T	5;5;6	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	712	mfd	3447	1941	99.23	mfd.l15.c30.ctg.1	2133	11.4	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	881	883	CTG	21;21;22	C;T;G	21;20;22	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	712	mfd	3447	424	99.29	mfd.l15.c30.ctg.2	610	7.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	513	712	mfd	3447	1067	99.34	mfd.l15.c30.ctg.3	1075	8.7	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	906	908	AAG	7;7;7	A;A;G	7;5;7	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	19	48	mgrB	144	141	100.0	mgrB.l6.c30.ctg.1	148	8.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	360	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1967	9.7	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1004	1006	AAC	9;9;10	A;A;C	9;9;10	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	360	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	1967	9.7	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1550	1552	ATA	15;15;15	A;T;A	15;15;15	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	318	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.2	1391	11.5	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1142	1144	GAT	15;14;15	G;A;T	15;14;15	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	318	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.2	1391	11.5	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1145	1147	CTG	14;15;14	C;T;G	14;15;14	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	0	.	p	.	0	R27C	NONSYN	79	81	CGT	116	118	TGT	7;7;6	T;G;T	7;7;6	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	0	.	p	.	0	I117T	NONSYN	349	351	ATC	386	388	ACC	7;7;7	A;C;C	7;7;7	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	0	.	p	.	0	Q182trunc	TRUNC	544	544	C	581	581	T	5	T	5	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	0	.	p	.	0	G187D	NONSYN	559	561	GGC	596	598	GAC	3;3;4	G;A;C	3;3;4	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	1	SNP	p	R15C	0	.	.	43	45	CGC	80	82	CGC	13;13;13	C;G;C	13;13;13	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	1	SNP	p	S33R	0	.	.	97	99	AGC	134	136	AGC	4;4;4	A;G;C	4;4;4	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	1	SNP	p	G131D	0	.	.	391	393	GGC	428	430	GGC	5;5;5	G;G;C	5;5;5	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	1	SNP	p	R203C	0	.	.	607	609	CGT	644	646	CGT	10;10;10	C;G;T	10;10;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	531	140	nfsA	723	723	98.89	nfsA.l15.c30.ctg.1	853	8.0	1	SNP	p	R203L	0	.	.	607	609	CGT	644	646	CGT	10;10;10	C;G;T	10;10;10	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	322	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1493	11.6	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1135	1137	GAG	12;12;12	G;A;G	12;12;12	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	322	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1493	11.6	1	SNP	p	G141E	0	.	.	421	423	GGT	622	624	GGT	17;17;17	G;G;T	17;17;17	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	322	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1493	11.6	1	SNP	p	G141D	0	.	.	421	423	GGT	622	624	GGT	17;17;17	G;G;T	17;17;17	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	322	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1493	11.6	1	SNP	p	R154A	0	.	.	460	462	CGT	661	663	CGT	12;12;13	C;G;T	12;12;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	322	ompF	1089	1089	99.91	ompF.l6.c30.ctg.1	1493	11.6	1	SNP	p	R154D	0	.	.	460	462	CGT	661	663	CGT	12;12;13	C;G;T	12;12;13	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1747	1749	GTG	15;15;16	G;T;G	15;15;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1774	1776	TCG	13;14;14	T;C;G	11;13;12	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2389	2391	AAC	8;8;8	A;A;C	8;8;8	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	1	SNP	p	A85T	0	.	.	253	255	GCG	403	405	GCG	14;14;14	G;C;G,A	13;14;13,1	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	1	SNP	p	D111H	0	.	.	331	333	GAT	481	483	GAT	11;10;10	G;A;T	11;10;10	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	622	parC_2	2259	2259	99.2	parC_2.l6.c4.ctg.1	2595	12.8	1	SNP	p	S129P	0	.	.	385	387	TCC	535	537	TCC	13;13;13	T;C;C	13;13;13	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	382	parE_1	1893	911	97.04	parE_1.l6.c4.ctg.1	1089	8.5	0	.	p	.	0	R54H	NONSYN	160	162	CGC	335	337	CAC	5;5;5	C;A,G;C	0;0,1;2	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	382	parE_1	1893	978	97.96	parE_1.l6.c4.ctg.2	1285	8.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	502	504	AAC	9;9;9	A;A;C	9;9;9	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	513	382	parE_1	1893	978	97.96	parE_1.l6.c4.ctg.2	1285	8.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	511	513	GAT	9;9;9	G;A;T	9;9;9	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	348	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1767	10.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	793	795	CAG	12;13;12	C;A;G	12;13;12	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	348	patA	1380	1380	99.78	patA.l15.c30.ctg.1	1767	10.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1267	1269	GAT	6;6;6	G;A;T	6;6;6	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	V146F	0	.	.	436	438	GTT	634	636	GTT	12;12;13	G;T;T	12;12;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1735	1737	CAG	10;10;10	C;A;G	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1735	1737	CAG	10;10;10	C;A;G	10;10;10	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1774	1776	CAC	13;13;13	C;A;C	13;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1783	1785	CGT	13;13;12	C;G;T	12;13;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1783	1785	CGT	13;13;12	C;G;T	12;13;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1789	1791	TCC	12;13;13	T;C;C	12;13;13	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1795	1797	CTC	12;12;12	C;T;C	12;12;12	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1885	1887	ACC	14;14;15	A;C;C	14;14;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1888	1890	CCT	15;15;15	C;C;T	15;15;15	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	1078	rpoB	4029	4029	99.01	rpoB.l15.c4.ctg.1	4447	13.0	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2257	2259	CGT	18;18;18	C;G;T	18;18;18	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	.	n	.	0	A226G	SNP	226	226	A	270	270	G	71	G	71	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	A794G	0	.	.	794	794	A	838	838	A	88	A	88	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	A794T	0	.	.	794	794	A	838	838	A	88	A	88	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	G926A	0	.	.	926	926	G	970	970	G	93	G	93	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	G926C	0	.	.	926	926	G	970	970	G	93	G	93	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	G926T	0	.	.	926	926	G	970	970	G	93	G	93	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	A1519T	0	.	.	1519	1519	A	1563	1563	A	57	A	57	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	A1519G	0	.	.	1519	1519	A	1563	1563	A	57	A	57	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	1	SNP	n	A1519C	0	.	.	1519	1519	A	1563	1563	A	57	A	57	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	C183T	.	183	183	C	227	227	C	89	C,T	61,28	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	C719T	.	719	719	C	763	763	C	84	C,T	50,34	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	T90C	.	90	90	T	134	134	T	83	T,C	62,21	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	A250T	.	250	250	A	294	294	A	76	A,T	56,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	G474A	.	474	474	G	518	518	G	97	G,A	73,24	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	A253T	.	253	253	A	297	297	A	76	A,T	56,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	C194T	.	194	194	C	238	238	C	81	C,T	64,17	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	G232A	.	232	232	G	276	276	G	65	G,A	55,10	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	G1002A	.	1002	1002	G	1046	1046	G	84	G,A	41,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	G1006C	.	1006	1006	G	1050	1050	G	83	G,C	39,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	A79G	.	79	79	A	123	123	A	82	A,G	62,20	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	T273A	.	273	273	T	317	317	T	80	T,A	63,17	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	T1010C	.	1010	1010	T	1054	1054	T	86	T,C	45,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	2944	rrsB+	1542	1542	99.94	rrsB+.l15.c30.ctg.1	1599	88.3	0	HET	.	.	.	C1038T	.	1038	1038	C	1082	1082	C	102	C,T	59,42	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	82	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	619	6.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli;sat-1
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	148	soxR	465	465	100.0	soxR.l15.c4.ctg.1	762	10.2	1	SNP	p	R20H	0	.	.	58	60	CGC	181	183	CGC	16;17;16	C;G;C	16;17;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	148	soxR	465	465	100.0	soxR.l15.c4.ctg.1	762	10.2	1	SNP	p	G121D	0	.	.	361	363	GGT	484	486	GGT	16;16;16	G;G;T	16;16;16	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	142	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	683	11.1	1	SNP	p	A12S	0	.	.	34	36	GCA	216	218	GCA	24;24;23	G;C;A	24;24;23	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	1	88	sul2	816	418	100.0	sul2.l15.c4.ctg.1	447	5.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	1	88	sul2	816	123	100.0	sul2.l15.c4.ctg.3	123	5.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	1	88	sul2	816	229	100.0	sul2.l15.c4.ctg.4	236	3.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	1	188	tet-	1206	687	100.0	tet-.l6.c30.ctg.1	838	6.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetA;TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	1	188	tet-	1206	492	100.0	tet-.l6.c30.ctg.2	536	7.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetA;TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	114	tetC	594	594	99.66	tetC.l6.c4.ctg.1	874	6.8	0	.	p	.	0	S152D	NONSYN	454	456	AGT	587	589	GAT	5;5;4	G;A;T	5;5;4	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	88	tetD	417	417	100.0	tetD.l6.c30.ctg.1	744	6.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tetD;TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	114	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	951	6.2	1	SNP	p	H64Y	0	.	.	190	192	CAC	353	355	CAC	7;7;7	C;A;C	7;7;7	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	114	tetR_2	627	627	100.0	tetR_2.l15.c4.ctg.1	951	6.2	1	SNP	p	N82H	0	.	.	244	246	AAT	407	409	AAT	5;6;6	A;A;T	5;6;6	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	114	tetR_1	624	624	100.0	tetR_1.l15.c4.ctg.1	951	6.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	334	tolC	1488	1488	98.72	tolC.l6.c4.ctg.1	1798	9.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
